ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION Drug Patent Profile

✉ Email this page to a colleague

When do Allegra-d 24 Hour Allergy And Congestion patents expire, and what generic alternatives are available?

Allegra-d 24 Hour Allergy And Congestion is a drug marketed by Chattem Sanofi and is included in one NDA.

The generic ingredient in ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Allegra-d 24 Hour Allergy And Congestion

A generic version of ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION was approved as fexofenadine hydrochloride; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on June 22^nd, 2011.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION?
What are the global sales for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION?
What is Average Wholesale Price for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION?

Summary for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	1
Patent Applications:	69
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION
DailyMed Link:	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION at DailyMed

Drug patent expirations by year for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

Pharmacology for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

Drug Class	Histamine-1 Receptor Antagonist alpha-Adrenergic Agonist
Mechanism of Action	Adrenergic alpha-Agonists Histamine H1 Receptor Antagonists

US Patents and Regulatory Information for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
Chattem Sanofi	ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION	fexofenadine hydrochloride; pseudoephedrine hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021704-002	Jan 24, 2011	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

See the table below for patents covering ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	H10500134		⤷ Sign Up
Finland	956270		⤷ Sign Up
China	1228020		⤷ Sign Up
Japan	2002316978	ANTIHISTAMINIC PIPERIDINE DERIVATIVE HAVING THE FORM IV AND METHOD FOR PRODUCING THE SAME DERIVATIVE	⤷ Sign Up
New Zealand	286641	4-KETO-ARALKYL CARBOXYLIC ACIDS AND ESTERS AS INTERMEDIATES	⤷ Sign Up
Japan	2007126478	MULTI-LAYERED PERMEATION DEVICE	⤷ Sign Up
European Patent Office	1178041		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

Pharmacology for ALLEGRA-D 24 HOUR ALLERGY AND CONGESTION

Make Better Decisions: Try a trial or see plans & pricing